ClinicalTrials.gov
ClinicalTrials.gov Menu

Mirtazapine for the Treatment of Methamphetamine Dependence Among MSM (M2.0)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01888835
Recruitment Status : Completed
First Posted : June 28, 2013
Last Update Posted : March 13, 2018
Sponsor:
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Phillip Coffin, MD, MIA, San Francisco Department of Public Health

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2017
  Actual Study Completion Date : October 2017